Tebentafusp: T Cell Redirection for the Treatment of Metastatic Uveal Melanoma
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tebentafusp: T Cell Redirection for the Treatment of Metastatic Uveal Melanoma
Authors
Keywords
-
Journal
Cancers
Volume 11, Issue 7, Pages 971
Publisher
MDPI AG
Online
2019-07-11
DOI
10.3390/cancers11070971
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- HER2 CAR-T cells eradicate uveal melanoma and T cell therapy-resistant human melanoma in interleukin-2 (IL-2) transgenic NOD/SCID IL-2 receptor knockout mice
- (2019) Elin MV Forsberg et al. CANCER RESEARCH
- Overall survival after treatment for metastatic uveal melanoma
- (2019) Elina S. Rantala et al. MELANOMA RESEARCH
- Response to Anti–PD-1 in Uveal Melanoma Without High-Volume Liver Metastasis
- (2019) Douglas B. Johnson et al. Journal of the National Comprehensive Cancer Network
- Clinical predictors of survival in metastatic uveal melanoma
- (2019) Daniel Lorenzo et al. JAPANESE JOURNAL OF OPHTHALMOLOGY
- Meta-analysis in metastatic uveal melanoma to determine progression free and overall survival benchmarks: an international rare cancers initiative (IRCI) ocular melanoma study
- (2019) L Khoja et al. ANNALS OF ONCOLOGY
- Patient-reported Outcomes and Quality of Life After Treatment of Choroidal Melanoma: A Comparison of Enucleation Versus Radiotherapy in 1596 Patients
- (2018) Bertil Damato et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- TIGIT immune checkpoint blockade restores CD8+T cell immunity against multiple myeloma
- (2018) Camille Guillerey et al. BLOOD
- Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma
- (2018) A. Gordon Robertson et al. CANCER CELL
- Selumetinib in Combination With Dacarbazine in Patients With Metastatic Uveal Melanoma: A Phase III, Multicenter, Randomized Trial (SUMIT)
- (2018) Richard D. Carvajal et al. JOURNAL OF CLINICAL ONCOLOGY
- New NCCN Guidelines for Uveal Melanoma and Treatment of Recurrent or Progressive Distant Metastatic Melanoma
- (2018) Christopher A. Barker et al. Journal of the National Comprehensive Cancer Network
- Ocular treatment of choroidal melanoma in relation to the prevention of metastatic death – A personal view
- (2018) Bertil Damato PROGRESS IN RETINAL AND EYE RESEARCH
- Targeting LAG-3 and PD-1 to Enhance T Cell Activation by Antigen-Presenting Cells
- (2018) Felix S. Lichtenegger et al. Frontiers in Immunology
- The Pharmacology of T Cell Therapies
- (2018) Michael C. Milone et al. Molecular Therapy-Methods & Clinical Development
- Early cost-effectiveness of tumor infiltrating lymphocytes (TIL) for second line treatment in advanced melanoma: a model-based economic evaluation
- (2018) Valesca P. Retèl et al. BMC CANCER
- Prognostication of metastatic death in uveal melanoma patients: A Markov multi-state model
- (2018) Antonio Eleuteri et al. COMPUTERS IN BIOLOGY AND MEDICINE
- An approved in vitro approach to preclinical safety and efficacy evaluation of engineered T cell receptor anti-CD3 bispecific (ImmTAC) molecules
- (2018) Jane Harper et al. PLoS One
- Efficacy of PD-1 or PD-L1 inhibitors and PD-L1 expression status in cancer: meta-analysis
- (2018) Xian Shen et al. BMJ-British Medical Journal
- T Cell–Inflamed versus Non-T Cell–Inflamed Tumors: A Conceptual Framework for Cancer Immunotherapy Drug Development and Combination Therapy Selection
- (2018) Jonathan A. Trujillo et al. Cancer Immunology Research
- TIM-3, a promising target for cancer immunotherapy
- (2018) Yayi He et al. OncoTargets and Therapy
- Polyfunctional response by ImmTAC (IMCgp100) redirected CD8+ and CD4+ T cells
- (2017) Caroline Boudousquie et al. IMMUNOLOGY
- PD-L1 expression in tumor metastasis is different between uveal melanoma and cutaneous melanoma
- (2017) Asad Javed et al. Immunotherapy
- Percutaneous hepatic perfusion with melphalan in uveal melanoma: A safe and effective treatment modality in an orphan disease
- (2017) Ioannis Karydis et al. JOURNAL OF SURGICAL ONCOLOGY
- Treatment of metastatic uveal melanoma with adoptive transfer of tumour-infiltrating lymphocytes: a single-centre, two-stage, single-arm, phase 2 study
- (2017) Smita S Chandran et al. LANCET ONCOLOGY
- Dysregulated GPCR Signaling and Therapeutic Options in Uveal Melanoma
- (2017) Vivian Chua et al. MOLECULAR CANCER RESEARCH
- Tumor Mutational Burden and Response Rate to PD-1 Inhibition
- (2017) Mark Yarchoan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tolerance through Education: How Tolerogenic Dendritic Cells Shape Immunity
- (2017) Matthias P. Domogalla et al. Frontiers in Immunology
- Metastatic disease from uveal melanoma: treatment options and future prospects
- (2016) Richard D Carvajal et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Clinical outcomes in metastatic uveal melanoma treated with PD-1 and PD-L1 antibodies
- (2016) Alain P. Algazi et al. CANCER
- Rationale for anti-GITR cancer immunotherapy
- (2016) Deborah A. Knee et al. EUROPEAN JOURNAL OF CANCER
- Targeting immune checkpoints in unresectable metastatic cutaneous melanoma: a systematic review and meta-analysis of anti-CTLA-4 and anti-PD-1 agents trials
- (2016) Seongseok Yun et al. Cancer Medicine
- Role of IL-2 in cancer immunotherapy
- (2016) Tao Jiang et al. OncoImmunology
- Genetically modified T cells in cancer therapy: opportunities and challenges
- (2015) M. Sharpe et al. Disease Models & Mechanisms
- ImmTACs for targeted cancer therapy: Why, what, how, and which
- (2015) Joanne Oates et al. MOLECULAR IMMUNOLOGY
- iTRAQ Quantitative Proteomic Comparison of Metastatic and Non-Metastatic Uveal Melanoma Tumors
- (2015) John W. Crabb et al. PLoS One
- Neoantigens in cancer immunotherapy
- (2015) T. N. Schumacher et al. SCIENCE
- Hepatic intra-arterial versus intravenous fotemustine in patients with liver metastases from uveal melanoma (EORTC 18021): a multicentric randomized trial
- (2014) S. Leyvraz et al. ANNALS OF ONCOLOGY
- ImmTAC-redirected tumour cell killing induces and potentiates antigen cross-presentation by dendritic cells
- (2014) Giovanna Bossi et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Effect of Selumetinib vs Chemotherapy on Progression-Free Survival in Uveal Melanoma
- (2014) Richard D. Carvajal et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Examining the presentation of tumor-associated antigens on peptide-pulsed T2 cells
- (2014) Giovanna Bossi et al. OncoImmunology
- Multi-cistronic vector encoding optimized safety switch for adoptive therapy with T-cell receptor-modified T cells
- (2013) M M van Loenen et al. GENE THERAPY
- Adoptive T Cell Transfer for Cancer Immunotherapy in the Era of Synthetic Biology
- (2013) Michael Kalos et al. IMMUNITY
- At the Bench: Preclinical rationale for CTLA-4 and PD-1 blockade as cancer immunotherapy
- (2013) Andrew M. Intlekofer et al. JOURNAL OF LEUKOCYTE BIOLOGY
- The Liverpool uveal melanoma liver metastases pathway: Outcome following liver resection
- (2013) D. Gomez et al. JOURNAL OF SURGICAL ONCOLOGY
- T Cells Expressing Chimeric Antigen Receptors Can Cause Anaphylaxis in Humans
- (2013) M. V. Maus et al. Cancer Immunology Research
- Role of T Cell Receptor Affinity in the Efficacy and Specificity of Adoptive T Cell Therapies
- (2013) Jennifer D. Stone et al. Frontiers in Immunology
- MRI in the detection of hepatic metastases from high-risk uveal melanoma: a prospective study in 188 patients
- (2012) Ernie Marshall et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Progress in the management of patients with uveal melanoma. The 2012 Ashton Lecture
- (2012) B Damato EYE
- Radiotherapy for ocular tumours
- (2012) C Stannard et al. EYE
- Activity of the oral MEK inhibitor trametinib in patients with advanced melanoma: a phase 1 dose-escalation trial
- (2012) Gerald S Falchook et al. LANCET ONCOLOGY
- Monoclonal TCR-redirected tumor cell killing
- (2012) Nathaniel Liddy et al. NATURE MEDICINE
- T-Cell Tolerance: Central and Peripheral
- (2012) Y. Xing et al. Cold Spring Harbor Perspectives in Biology
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- 9304 ORAL Percutaneous Hepatic Perfusion (PHP) Vs. Best Alternative Care (BAC) for Patients (pts) With Melanoma Liver Metastases – Efficacy Update of the Phase 3 Trial (NCT00324727)
- (2011) J.F. Pinqpank et al. EUROPEAN JOURNAL OF CANCER
- Differences in uveal melanomas between men and women from the British Isles
- (2011) B E Damato et al. EYE
- Science gone translational: the OX40 agonist story
- (2011) Andrew D. Weinberg et al. IMMUNOLOGICAL REVIEWS
- Uveal Melanoma: Trends in Incidence, Treatment, and Survival
- (2011) Arun D. Singh et al. OPHTHALMOLOGY
- Estimating prognosis for survival after treatment of choroidal melanoma
- (2011) Bertil Damato et al. PROGRESS IN RETINAL AND EYE RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search